Wegovy® without insurance — paying cash in 2026
If your insurance denies Wegovy® — or you'd rather skip insurance entirely — Imbue ships brand-name Wegovy® from NovoCare at the manufacturer's cash-pay rate of $199/mo. Plus a $29/mo physician membership. Total: $228–$428/mo (by dose).
Last clinically reviewed: June 7, 2026 by the Imbue Health Medical Team
Why insurance keeps denying Wegovy®
Weight-loss exclusions
Many employer and marketplace plans explicitly exclude GLP-1s when prescribed for weight management, even when they cover the same drug for diabetes.
Step therapy & prior authorisation
Plans that do cover Wegovy® often require you to fail cheaper medications first, then submit a prior-authorisation request that can take weeks — and still be denied.
Specialty-tier copays
When approved, Wegovy® frequently lands on a high specialty tier, leaving a copay that can rival — or exceed — the cash-pay price.
Not sure where your plan stands? Our Insurance & GLP-1 Coverage guide covers when using insurance is actually the cheaper route.
Wegovy® through Imbue Health
Membership
$29/mo
Medication
$199/mo
via NovoCare
Total all-in
$228/mo
up to $428/mo (higher doses)
How the cash-pay path works
- 1
Complete your intake
A short online medical questionnaire about your health history and weight-loss goals. The $29/month membership covers the physician review.
- 2
Physician confirms eligibility
A U.S.-licensed physician reviews your intake and, if Wegovy® is appropriate, writes the prescription. If it isn't, you aren't charged.
- 3
Prescription routes to NovoCare
Your prescription goes directly to Novo Nordisk's NovoCare pharmacy program — no pharmacy counter, no insurance middleman.
- 4
Medication ships to your door
NovoCare dispenses brand-name Wegovy® at the $199/month cash-pay rate and ships it to you.
- 5
Ongoing care included
Dose adjustments, refills, and clinician messaging stay included in your flat $29/month membership.
Cash-pay vs fighting your insurer
Paying cash isn't always the obvious choice — but for Wegovy® it often wins on both price and time. With Imbue you pay a predictable $228/month all-in at the starting dose: no deductible to burn through, no prior-authorisation wait, no risk of a denial after weeks of back-and-forth.
If your plan genuinely covers Wegovy® at a low copay, insurance may still be cheaper — and we'll tell you so. But if you're facing an exclusion, step therapy, or a specialty-tier copay near the cash price, the manufacturer cash-pay route through NovoCare is usually faster and more predictable.
Eligibility for Wegovy®
No insurance is required to qualify — but the clinical criteria still apply. Wegovy® eligibility through Imbue:
- Adults 18 and older in all 50 U.S. states and Washington, D.C.
- BMI ≥30, or BMI ≥25 with at least one weight-related condition (hypertension, type 2 diabetes, dyslipidemia, sleep apnea, cardiovascular disease).
- No personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
BMI 25–26.9 is below FDA label thresholds and prescribed at the provider's discretion. BMI under 25 may be considered in cases of abnormal weight gain, at the provider's discretion.
Related pages on Imbue Health
Get Wegovy® without the insurance maze
Brand-name Wegovy® via NovoCare cash-pay at $199/mo + $29/mo membership. No prior authorisation, no denials.